Assessing Physician and Hemophilia A Patient Reasons and Expectations for Switching Treatment to Kovaltry & Jivi: A Nested Study Within an Existing Registry
Stopped early
Conditions studied: Hemophilia A
In brief
This US study aims to assess hemophilia A patient characteristics and reasons for switching from both patient/caregiver and physician perspectives. For this purpose, this research study will include hemophilia A patients who have switched from an existing therapy to Kovaltry or Jivi. In doing so, real world evidence will be obtained from both patient and physician perspectives offering key insights for effective therapeutic management of patients with hemophilia A and to more fully understand what drives patient switching from a patient perspective and a physician perspective.
Key facts
- Study ID
- NCT03603275
- Run by
- Bayer
- People needed
- 3
- Starts
- 2018-08-06
- Expected to finish
- 2020-05-14
- Last updated by the study team
- 2022-08-25
Who can join
Age: 2 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of California, San Diego — La Jolla, California, United States
- University of Colorado Denver Hemophilia and Thrombosis Center — Aurora, Colorado, United States
- Yale Hemophilia Treatment Center — New Haven, Connecticut, United States
- Children's National Medical Center — Washington D.C., District of Columbia, United States
- Johns Hopkins All Children's Hospital — St. Petersburg, Florida, United States
- St. Josephs Hemophilia Treatment Center — Tampa, Florida, United States
- Emory / Children's Healthcare of Atlanta — Atlanta, Georgia, United States
- Bleeding and Clotting Disorders Institute — Peoria, Illinois, United States
- Indiana Hemophilia and Thrombosis Center IHTC — Indianapolis, Indiana, United States
- Louisiana Center for Bleeding and Clotting Disorders / Tulane — New Orleans, Louisiana, United States
- Maine Hemophilia and Thrombosis Center — Scarborough, Maine, United States
- The Johns Hopkins University Hemophilia Treatment Center — Baltimore, Maryland, United States
- Boston Hemophilia Center at Children's Hospital of Boston/Brigham Women's — Boston, Massachusetts, United States
- Univ of Michigan Hemophilia and Coagulation Disorders — Ann Arbor, Michigan, United States
- Michigan State University Center for Bleeding Disorders & Clotting Disorders — East Lansing, Michigan, United States
- Children's Mercy Hospital (Kansas City) — Kansas City, Missouri, United States
- Dartmouth-Hitchcock Comprehensive Hemophilia and Thrombosis Center — Lebanon, New Hampshire, United States
- Weill Cornell Medicine — New York, New York, United States
- Mary M. Gooley Hemophilia Center, Inc. — Rochester, New York, United States
- Oregon Health & Science University — Portland, Oregon, United States
- Children's Hospital of Philadelphia (CHOP) — Philadelphia, Pennsylvania, United States
- Penn Comprehensive Hemophilia and Thrombophilia Program / Hospital UPENN — Philadelphia, Pennsylvania, United States
- Hemophilia Center of Western Pennsylvania — Pittsburgh, Pennsylvania, United States
- St. Jude Children's Research Hospital — Memphis, Tennessee, United States
- UT Southwestern/Children's Health Dallas — Dallas, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.